Strategies to delay the onset of Alzheimer's disease. (Q34039304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Strategies to delay the onset of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

M H Hüll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B L Fiebich

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Lieb

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

211-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Amyloid, the presenilins and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Presenilin 1 interaction in the brain with a novel member of the Armadillo family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The presenilins and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

APOE genotyping and Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Apolipoprotein E alleles as risk factors in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The toxicity in vitro of beta-amyloid protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Alzheimer's disease. Amyloid ox-tox transducers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Lack of long-term effects after beta-amyloid protein injections in rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Frequency of stages of Alzheimer-related lesions in different age categories

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Role of microglia in senile plaque formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Senile plaques do not progressively accumulate with normal aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Decreased expression of prostaglandin G/H synthase-2 (PGHS-2) in Alzheimer's disease brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The basal forebrain cholinergic system and object memory in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Metabotropic Glutamate Receptor Subtype mGluR1α Stimulates the Secretion of the Amyloid β‐Protein Precursor Ectodomain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

PKC and tyrosine kinase involvement in amyloid beta (25-35)-induced chemotaxis of microglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Indomethacin reverses the microglial response to amyloid beta-protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Adenosine and propentofylline inhibit the proliferation of cultured microglial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Clinical trials in dementia with propentofylline

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Clinical trial of indomethacin in Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The epidemiology of estrogen replacement therapy and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

The role of estrogen in the treatment of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Glucocorticoids in Alzheimer's disease. The story so far.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Gonadal and adrenal steroids regulate neurochemical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Stress-Induced Declarative Memory Impairment in Healthy Elderly Subjects: Relationship to Cortisol Reactivity1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8393-1_13

10.1007/978-3-0348-8393-1_13

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997291%20AND%20SRC:MED&resulttype=core&format=json